Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Tahaniyat Lalani, Anthony C Fries et al.|Clinical Infectious Diseases|2022Cited by 59
Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Daniel E. Clark, Eric D. Laing et al.|The Journal of Infectious Diseases|2021Cited by 42
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionI Scher, LTC D Hostler, Catherine M Berjohn et al.|Open Forum Infectious Diseases|2022Cited by 8
Critical COVID-19 disease explained by type I interferon autoantibodies found in patients within the Military Health SystemAndrew L. Snow, Maria Leondaridis, Debra Yee et al.|The Journal of Immunology|2023Cited by 0